OHSU Cancer Institute-Southern Region — Medford, Oregon

OHSU Cancer Institute-Southern Region is a clinical research site located in Medford, Oregon, United States 97504.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

OHSU Cancer Institute-Southern Region has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma.

Sponsors: Fred Hutchinson Cancer Center.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OHSU Cancer Institute-Southern Region?

OHSU Cancer Institute-Southern Region has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OHSU Cancer Institute-Southern Region conducted?

OHSU Cancer Institute-Southern Region has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma.

Is OHSU Cancer Institute-Southern Region accredited by Crixeo Health?

OHSU Cancer Institute-Southern Region has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OHSU Cancer Institute-Southern Region?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.